Related Experiment Videos
Cost and cost-effectiveness of cardiac surgery in elderly patients
Sandro Gelsomino1, Roberto Lorusso, Ugolino Livi
1Cardiac Surgery Unit, Careggi Hospital, Florence, Italy. sandro.gelsomino@libero.it
Insights
Cardiac surgery in octogenarians improved quality of life but had higher costs. The cost-effectiveness ratio for elderly surgical patients was $94,426, indicating ongoing debate in healthcare economics.
Area of Science:
- Cardiovascular Surgery
- Health Economics
- Geriatric Medicine
Background:
- The cost-effectiveness of cardiac surgery for elderly patients, particularly octogenarians, is not well-established.
- Evaluating outcomes, quality of life (QoL), and economic impact is crucial for informed clinical decisions.
Purpose of the Study:
- To assess the outcome, quality of life (QoL), cost, and cost-effectiveness of octogenarians undergoing cardiac surgery.
- To compare these metrics with younger cardiac surgery patients and control groups.
Main Methods:
- Prospective study of 1640 octogenarians undergoing cardiac surgery (1998-2009), compared to 70-79 year olds.
- QoL assessed via questionnaires; costs obtained from hospital financial data.
- Cost-effectiveness analyzed using cost per QoL-adjusted life year (QALY) and cost-effectiveness ratio.
Main Results:
- Elderly surgical patients showed significant QoL improvements in physical role, pain, general health, and social/role emotional functioning.
- Total direct costs were $5293 higher in octogenarians compared to younger patients.
- Cost-effectiveness was $1391/QALY for elderly surgical patients, with a cost-effectiveness ratio of $94,426.
Conclusions:
- Cardiac surgery in the elderly remains controversial regarding cost-effectiveness.
- Econometric analysis is vital for evaluating new cardiovascular therapies in this population.
- Further multicenter studies are needed to validate these findings.
Objective:
Cost-effectiveness of heart surgery for elderly patients is still poorly defined. We evaluated outcome, quality of life (QoL), cost, and cost-effectiveness of octogenarians undergoing cardiac surgery.
Methods:
One thousand six hundred forty octogenarians undergoing various cardiac surgical procedures were prospectively studied between January 1998 and January 2009 and compared with similar patients aged 70 to 79 years. Several questionnaires were used to assess QoL. Six hundred age- and sex- matched healthy octogenarians and three hundred forty patients older than 80 years with medically treated valvular or coronary artery disease were healthy and unoperated control groups, respectively. In-hospital costs were obtained from the hospital's financial accounting department and cost-effectiveness was estimated and expressed as cost/QoL-adjusted life year (QALY) and cost-effectiveness ratio.
Results:
Significant improvements occurred in elderly patients in Role Physical (P < .001), Bodily Pain (P < .001), General Health (P = .004), Social Functioning (P < .001), and Role Emotional (P < .001), whereas Physical Functioning, Vitality, and Mental Health did not change (difference not signficant). Total direct costs were $5293 higher in the octogenarian group. Cost-effectiveness was $1391/QALY for elderly surgical patients, $516/QALY for younger cardiac surgical patients (P < .001 vs elderly), $897/QALY for untreated control group, and $641/QALY for healthy control group (P < .001 vs elderly surgical patients). The cost-effectiveness ratio for octogenarians was $94,426.
Conclusions:
Our findings confirm that cardiac surgery in elderly patients remains controversial from a cost-effectiveness standpoint, making econometric analysis an important component for any future evaluation of novel cardiovascular therapies. Our findings need to be confirmed by additional multicenter studies.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Drug Dosing: Geriatric Patients
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution